台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    68.0
  • 漲跌
    ▲3.5
  • 漲幅
    +5.43%
  • 成交量
    177
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-統一-竹南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-竹南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/02/0200.000.145.5046.10-0.1153-0.07%
2023/06/2600.00921.7021.65-998-9.15%
2023/06/06923.8200.0024.1091396.45%
2023/06/050.124.5000.0024.800.11370.07%
2022/07/2700.00213.9514.15-2109-1.83%
2022/07/25213.7500.0013.752832.38%
2022/05/0600.001015.0015.15-10141-7.08%
2022/04/181016.9500.0016.95109210.85%
2021/05/1700.001719.3919.60-17506-3.36%
2021/05/131018.7500.0019.55104342.30%
2021/04/2800.002017.7517.75-20349-5.72%
2021/04/2300.003017.0117.15-30344-8.72%
2021/04/1600.001018.1118.20-10332-3.00%
2021/04/14117.5000.0017.3013280.30%
2021/04/132519.5100.0018.20253227.74%
2021/04/122218.1900.0018.80222947.47%
2021/04/09117.2500.0017.1012750.36%
2021/04/082717.1100.0017.25272739.89%
2020/08/0500.00225.1025.05-22,289-0.09%
2020/08/0400.00225.0525.50-22,278-0.09%
2020/07/3000.00326.0025.25-32,272-0.13%
2020/07/1600.002029.5029.05-202,018-0.99%
2020/07/10627.9500.0028.7061,6660.36%
2020/07/082021.9500.0023.75201,5161.32%
2020/06/1700.001425.2325.35-141,350-1.04%
2020/06/16324.8800.0025.9031,2940.23%
2020/06/151023.40122.6524.2091,2070.75%
2020/06/11320.7800.0021.0031,0770.28%
2020/02/0400.00210.9010.80-2156-1.28%
2019/10/2300.00810.0510.15-894-8.45%
2019/07/1900.00111.8011.75-1134-0.74%
2019/07/18112.20411.8012.20-3123-2.43%
2019/07/16211.1500.0011.0021041.91%
2019/07/12411.5300.0011.1541023.90%
2019/01/1800.00113.1513.15-1107-0.93%
2019/01/14114.1000.0014.001941.06%
2018/04/2500.001020.0019.80-10370-2.70%
2018/04/191820.2100.0020.90183585.02%
2018/04/1300.00523.5523.70-5302-1.65%
2018/04/1000.00222.8522.85-2189-1.05%
2018/03/2900.00219.2519.15-2178-1.12%
2018/03/28219.0000.0018.9021831.09%
2018/03/26219.7000.0019.7021871.07%
2018/01/0500.00118.9018.90-1185-0.54%
2018/01/04119.2000.0019.2011830.54%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音